We develop a new TMS targeting algorithm and test it in an open label trial in a treatment-resistant depression population with high comorbidities. Preprints by @rubykong92.bsky.social Phern-Chern Tor 1. doi.org/10.1101/2025... 2. doi.org/10.64898/202... Our new approach ...

Super thankful to @bttyeo.bsky.social @csabaorban.bsky.social and @shaoshiz.bsky.social for pouring in all the effort to make this work possible!